The Hoosier Oncology Group operates as a cancer research organization established to evaluate
innovative and promising methods and approaches to cancer treatment through, among other things,
clinical research. Engendering cooperation between medical center scientists and community practitioners
enables HOG to achieve the goal of treating cancer patients within their own communities, while contributing
significant research to the worldwide battle against cancer.
Hoosier Oncology Group Welcomes
Hoosier Oncology Group is very pleased to announce that Christopher A. Fausel, Pharm.D., MHA, BCOP, was appointed Chairman of the Board of Directors on July 31, 2013.
Hoosier Oncology Group named administrative headquarters for the newly formed Big Ten Cancer Research Consortium (BTCRC)
Read More about BTCRC...
View the Kick-off Event meeting presentations
Borealis-2 bladder cancer study
Hoosier Oncology Group GU12-160
Read the Press Release
Read more information about this trial
Find Us on Facebook!